Bafna Pharmaceuticals Limited

NSE:BAFNAPH.NS

81.76 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 73.479117.69173.07658.267-18.834-182.928-147.166-203.627-140.26961.77424.91254.92153.71447.37739.65224.77812.97711.17
Depreciation & Amortization 49.95453.34454.93344.78232.66634.76239.74142.19548.58659.85589.93882.49763.02822.65917.37913.7153.4573.684
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital -52.795-145.733-12.805-232.53-129.73110.576271.955-16.123.943332.708-207.679149.101-240.961-170.915-84.353-194.84-41.57790.063
Accounts Receivables -48.737-270.419-61.121-35.247187.99-5.543294.964141.88578.3888.281-58.861-77.856000000
Inventory -74.231-19.391-48.372-40.309-21.29213.91960.657-3.601-2.571112.792-51.89317.062-87.567-54.095-46.8147.14511.899-15.893
Accounts Payables 69.619160.558122.177-18.498-268.826109.48447.059-137.9650000000000
Other Working Capital 0.554-16.481-25.489-138.476-27.602-7.284211.298-12.5196.514219.916-155.787132.038-153.394-116.82-37.538-201.986-53.476105.956
Other Non Cash Items 155.59424.223-34.886-6.608-227.18919.718-235.003103.33596.85-347.687108.8979.80428.20637.34721.37616.5234.206-3.86
Operating Cash Flow 72.97549.52580.318-136.089-343.087-17.872-70.473-74.2169.11106.6516.062366.322-96.013-63.532-5.946-139.824-20.937101.057
Investing Activities:
Investments In Property Plant And Equipment -158.482-82.186-75.411-60.947-14.288-3.331-1.265-0.791-23.069-77.899-17.527-21.277-299.791-107.854-33.648-61.698-69.352-187.014
Acquisitions Net 1.7111.96400049.324469.36400000000000
Purchases Of Investments 000000000000000000
Sales Maturities Of Investments 000000000150.938000000015
Other Investing Activites 55.29721.0217.493342.036103.295380.9611.34119.45528.22-49.545-39.693-9.4042.8441.9586.2910.4921.485
Investing Cash Flow -151.771-74.925-54.39-53.454327.748149.288379.69510.551-3.619601.259-67.072-60.97-309.195-105.01-31.69-55.407-68.86-170.529
Financing Activities:
Debt Repayment -14.654-118.645-47.266-123.684-232.397-0.514-200.819-19.349-117.053-404.6620-0.43000000
Common Stock Issued 0000553.55813.801120400009.75676.2598.360233.15312.89524.925
Common Stock Repurchased 000000000-16900000000
Dividends Paid 00000000000-11.194000000
Other Financing Activities -23.108220.4155.031246.482-248.147-147.081-225.46942.456110.999-134.607-131.637-129.047234.35169.56935.73-29.51471.14351.39
Financing Cash Flow 14.654101.77-42.235122.79873.014-133.794-306.28863.107-6.054-708.269-131.637-119.291310.6267.92935.73203.63984.03876.315
Other Information:
Effect Of Forex Changes On Cash 000-0.019-0.006-0.002-0.0010-0-2000-0000-00170.529
Net Change In Cash -64.1476.37-16.307-66.76457.675-2.382.933-0.559-0.564-200.36-182.647186.061-94.60899.387-1.9068.408-5.759177.373
Cash At End Of Period 13.9678.11.7318.03784.80727.13229.51226.57927.13827.70228.062210.70924.648117.818.41220.31911.91188.198